Fulcrum Therapeutics, Inc. (FULC)
7.81
-0.57
(-6.80%)
USD |
NASDAQ |
Mar 02, 16:00
7.77
-0.04
(-0.51%)
After-Hours: 20:00
Fulcrum Therapeutics EPS Diluted (Quarterly) : -0.3091 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.33M |
| Total Expenses (Quarterly) | 20.33M |
| Enterprise Value | 174.28M |
| Earnings Yield | -15.12% |
| Normalized Earnings Yield | -15.13 |